CN Patent
CN106414402A — 丙烯酰(氧基或氨基)五氟硫烷基苯化合物、其药学可接受的盐及其前药
Assigned to Ube Corp · Expires 2017-02-15 · 9y expired
What this patent protects
提供一种具有药理作用的丙烯酰(氧基或氨基)五氟硫烷基苯化合物。本发明涉及一种由通式(A‑I)表示的丙烯酰(氧基或氨基)五氟硫烷基苯化合物、其药学上可接受的盐及其前药; 其中所有参数代表如在说明书中所定义的相同的含义。
USPTO Abstract
提供一种具有药理作用的丙烯酰(氧基或氨基)五氟硫烷基苯化合物。本发明涉及一种由通式(A‑I)表示的丙烯酰(氧基或氨基)五氟硫烷基苯化合物、其药学上可接受的盐及其前药; 其中所有参数代表如在说明书中所定义的相同的含义。
Drugs covered by this patent
- Scemblix (ASCIMINIB HYDROCHLORIDE) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.